In the TCGA NSCLC cohort, consistently, the associations of HSPG2 mutations with higher TMB and NB were also noticed (Wilcoxon rank sum test both p < 0.001; Figure 5D,E). Here, HSPG2 is linked to non-small cell lung carcinoma.